IP Library Granted Patent US 8,094,779
Granted Patent B2
US 8,094,779 · App. 12/755,371 · Granted Jan 10, 2012

Orthovoltage radiotherapy

Assignee: Oraya Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,094,779
App. No.
12/755,371
Granted
Jan 10, 2012
Kind
B2
Abstract

A radiosurgery system is described that is configured to deliver a therapeutic dose of radiation to a target structure in a patient. In some embodiments, inflammatory ocular disorders are treated, specifically macular degeneration. In some embodiments, the ocular structures are placed in a global coordinate system based on ocular imaging. In some embodiments, the ocular structures inside the global coordinate system lead to direction of an automated positioning system that is directed based on the ocular structures within the coordinate system. In some embodiments, the position of the ocular structure is tracked and related to the status of the radiosurgery system. In some embodiments, a treatment plan is utilized in which beam energy and direction and duration of time for treatment is determined for a specific disease to be treated and/or structures to be avoided. In some embodiments, the structure is an eye and the eye is tracked by the system. In some embodiments, the eye is held in place and in some embodiments, the eye is fixed by the patient. In some embodiments, a fiducial is placed on the eye to aid in positioning. In some embodiments, a reflection off the eye is used to aid in positioning. In some embodiments, radiodynamic therapy is described in which radiosurgery is used in combination with other treatments and can be delivered concomitant with, prior to, or following other treatments.

Claims (34)

1. A method, for treating diseased tissue with radiation, comprising:

selecting a target disease from among a plurality of diseases, each of the plurality of diseases having an associated therapeutic dose of radiation;

determining, based on the target disease, a maximal energy in an x-ray radiation beam to be emitted from a radiotherapy system, the x-ray radiation beam delivering substantially the therapeutic dose of radiation associated with the target disease to target tissue in a patient afflicted by the target disease;

wherein diseases of the plurality of diseases require a different maximal energy of the x-ray radiation beam to achieve the associated therapeutic dose of radiation than the maximal energy required to achieve the associated therapeutic dose of radiation for another disease of the plurality of diseases; and

wherein the maximal energy in the x-ray radiation beam is based on the selected target disease and beam energy attenuation due to any tissue overlying the target tissue; and

outputting to an output module an indication of the determined maximal energy.

2. The method of claim 1 , wherein the therapeutic dose of radiation associated with the target disease comprises a plurality of fractionated doses.

3. The method of claim 1 , wherein the target disease affects an eye of the patient and the radiation beam is emitted toward the eye.

4. The method of claim 3 , wherein the plurality of diseases comprises at least one of macular degeneration, a pterygium, an ocular tumor, diabetic retinopathy, glaucoma, and a premalignant lesion.

5. The method of claim 1 , further comprising emitting x-ray radiation, based on the determined energy level, toward the target tissue to deliver a dose of radiation to the tissue.

6. The method of claim 5 , further comprising collimating the radiation to a radiation beam having cross-sectional dimension of less than about 6 mm.

7. The method of claim 5 , wherein the emitting comprises emitting a plurality of radiation beams toward the target tissue to deliver a dose of radiation to the tissue.

8. The method of claim 5 , wherein the emitting comprises emitting x-ray radiation toward the target tissue to deliver a dose of radiation to the tissue.

9. The method of claim 8 , wherein the emitting x-ray radiation comprises emitting a plurality of x-ray beams toward the tissue.

10. A system, for treating diseased tissue with radiation, comprising:

a processing module that receives an input, the input comprising a selection of a target disease from among a plurality of diseases, each of the plurality of diseases having an associated therapeutic dose of radiation, the processing module further determining, based on the target disease, a maximal energy in an x-ray radiation beam to be emitted from a radiotherapy system, the x-ray radiation beam delivering substantially the therapeutic dose of radiation associated with the target disease to target tissue in a patient afflicted by the target disease;

wherein diseases of the plurality of diseases require a different maximal energy of the x-ray radiation beam to achieve the associated therapeutic dose of radiation than the maximal energy to achieve the associated therapeutic dose of radiation for another disease of the plurality of diseases; and

wherein the maximal energy in the x-ray radiation beam is based on the selected target disease and beam energy attenuation due to any tissue overlying the target tissue; and

an output module, coupled to the processing module, that outputs, based on the input, an indication of the determined maximal energy.

11. The system of claim 10 , further comprising the radiotherapy system, wherein the radiotherapy system is coupled to the output module and is configured to generate the radiation beam based on the indication of the determined maximal energy.

12. The system of claim 11 , wherein the radiotherapy system comprises a power supply adapted to deliver between about 10 mA and about 800 mA of current to an anode of an x-ray tube that generates x-ray radiation.

13. The system of claim 12 , wherein said anode is one of a stationary anode and a rotating anode.

14. The system of claim 12 , wherein the radiotherapy system further comprises a collimator that collimates the x-ray radiation to an x-ray beam having a cross-sectional dimension of less than about 6 mm.

15. A method, for treating diseased tissue with radiation, comprising:

selecting a target disease from among a plurality of diseases, the plurality of diseases having associated therapeutic doses of radiation;

determining, based on the target disease, a maximal energy in an x-ray radiation beam to be emitted from a radiotherapy system, the radiation beam delivering substantially the therapeutic dose of radiation associated with the target disease to target tissue in a patient afflicted by the target disease; and

outputting to an output module an indication of the determined maximal energy;

inputting a maximum voltage to an x-ray tube of the radiotherapy system to a value of between about 30 kV and about 300 kV, based on the determined maximal energy;

wherein diseases of the plurality of diseases require a different maximal energy and/or surface-to-depth ratio to achieve the associated therapeutic dose of radiation for that disease than is required to achieve the associated therapeutic dose of radiation for other diseases of the plurality of diseases.

16. The method of claim 15 , further comprising communicating the indication of the determined maximal energy from the output module to the radiotherapy system.

17. The method of claim 16 , further comprising emitting the radiation beam, based on the indication of the determined maximal energy, from the radiotherapy system toward the target tissue.

18. The method of claim 17 , further comprising collimating the x-ray beam with a collimator, such that the x-ray beam has a cross-sectional dimension of less than about 6 mm.

19. The method of claim 17 , wherein the emitting comprises emitting a plurality of x-ray beams toward the target tissue to deliver fractionated doses of radiation to the tissue.

20. The method of claim 15 , wherein the plurality of diseases comprises at least one of macular degeneration, a pterygium, an ocular tumor, diabetic retinopathy, glaucoma, and a premalignant lesion.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: ORAYA THERAPEUTICS, INC.
To: CARL ZEISS MEDITEC, INC.
Reel/Frame 047256/0355 →
SECURITY INTEREST Recorded Feb 10, 2015
From: ORAYA THERAPEUTICS, INC.
To: CARL ZEISS MEDITEC, INC.
Reel/Frame 034934/0915 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2011
From: GERTNER, MICHAEL; CHELL, ERIK; HANSEN, STEVEN D.; ARNOLDUSSEN, MARK; HERRON, MATT; PAN, KUANG-HUNG
To: ORAYA THERAPEUTICS, INC.
Reel/Frame 027308/0995 →
Continuity (9)
Continuation 12024934 · Feb 1, 2008
Continuation 11873386 · Oct 16, 2007
Provisional Application 60933220 · Jun 4, 2007
Provisional Application 60922741 · Apr 9, 2007
Provisional Application 60869872 · Dec 13, 2006
Provisional Application 60862210 · Oct 19, 2006
Provisional Application 60862044 · Oct 18, 2006
Provisional Application 60829676 · Oct 16, 2006
Related Publication 20100195794A1 · Aug 5, 2010